Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

University of Toronto

$235,448.00

Engineering DNAzyme-gold nanoparticle diagnostic device

EF 2019-20

Résumé
Mosquitos carry many infectious pathogens that can significantly affect a patient's health aswell as other people that the patients come into contact with. Currently, there is a major globalscare with the transmission of the Zika virus, which has been implicated in cerebral brainmalformations among fetuses and newborns. Given advances in transportation vehicles,there is a significant risk of the virus being imported back to countries where the mosquitoscarry it are found. There remains an urgent need to develop simple methods to rapidlydiagnose Zika virus infection as it continues to spread to new locations. Rapid diagnosis inareas with reduced access to testing laboratories will allow appropriate management ofpregnant women who become infected and implement control measures as the virus spreadsto new, often remote areas. Here, in this project, our aim is to develop a unique colour-basedtest using nanotechnology components to be able to rapidly diagnose patients that arepresenting symptoms for the Zika virus, as well as two other important mosquito borneviruses, dengue and chikungunya virus. Testing of the 3 viruses is important to determineproper treatment, as patients infected with either of three viruses may present the samesymptoms. We will further develop a smartphone readout system that enables thequantification and monitoring of transmission of Zika virus. A team consisting of an engineerand two medical doctors is assembled to build and test this diagnostic device. Ourcommercial partners have the infrastructure to build the device and reagents, test thediagnostic systems, and to globally sell and distribute the technology for use in patient care.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523436-2018
Name nom
Chan, Warren
Department département
Biomaterials and Biomedical Engineering, Inst. of (IBBME)
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
235448
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Engineering DNAzyme-gold nanoparticle diagnostic device
Keyword
NSERC
Application summary
Mosquitos carry many infectious pathogens that can significantly affect a patient's health aswell as other people that the patients come into contact with. Currently, there is a major globalscare with the transmission of the Zika virus, which has been implicated in cerebral brainmalformations among fetuses and newborns. Given advances in transportation vehicles,there is a significant risk of the virus being imported back to countries where the mosquitoscarry it are found. There remains an urgent need to develop simple methods to rapidlydiagnose Zika virus infection as it continues to spread to new locations. Rapid diagnosis inareas with reduced access to testing laboratories will allow appropriate management ofpregnant women who become infected and implement control measures as the virus spreadsto new, often remote areas. Here, in this project, our aim is to develop a unique colour-basedtest using nanotechnology components to be able to rapidly diagnose patients that arepresenting symptoms for the Zika virus, as well as two other important mosquito borneviruses, dengue and chikungunya virus. Testing of the 3 viruses is important to determineproper treatment, as patients infected with either of three viruses may present the samesymptoms. We will further develop a smartphone readout system that enables thequantification and monitoring of transmission of Zika virus. A team consisting of an engineerand two medical doctors is assembled to build and test this diagnostic device. Ourcommercial partners have the infrastructure to build the device and reagents, test thediagnostic systems, and to globally sell and distribute the technology for use in patient care.